Drug Pipeline

rHuPH20 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
1
Phase 3
2
Top Sponsors
Active Studies by Phase
Phase 3
1
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05625399 A Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination (FDC) in Previously… Melanoma Active, Not Recruiting
Phase 2
NCT05996471 A Study to Investigate the Virologic Efficacy and Safety of VH3810109 + Cabotegravir… HIV Infections Active, Not Recruiting
Phase 1
NCT06310551 First Time in Human Study of Long Acting VH4524184 Formulations HIV Infections Recruiting
Sponsors Running rHuPH20 Trials
ViiV Healthcare (2) Bristol-Myers Squibb (1)
Disease Areas
Melanoma (1)
Get alerts when rHuPH20 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free